References
- Cheng C, Bai J. Association between polypharmacy, anxiety, and depression among Chinese older adults: evidence from the Chinese longitudinal healthy longevity survey. Clin Interv Aging. 2022;17:235–244. doi:10.2147/CIA.S351731
- By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67:674–694. doi:10.1111/jgs.15767
- Zhou SF, Lai X. An update on clinical drug interactions with the herbal antidepressant St. John’s wort. Curr Drug Metab. 2008;9:394–409. doi:10.2174/138920008784746391
- Rizza S, Piciucchi G, Mavilio M, et al. Effect of deprescribing in elderly patients with type 2 diabetes: iDegLira might improve quality of life. Biomed Pharmacother. 2021;144:112341. doi:10.1016/j.biopha.2021.112341
- Ailabouni N, Mangin D, Nishtala PS. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm. 2019;41:167–178. doi:10.1007/s11096-019-00784-9